Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization
Figure 1
Fluorescein angiography and horizontal optic coherence tomography findings in mid and early group patients. (a) Fluorescein angiography at late stage and (b) horizontal optic coherence tomography cross-sections of the macula in the right eye of a 28-year-old woman with subretinal idiopathic choroidal neovascularization and intraretinal edema. Her best-corrected visual acuity (BCVA) was 63 letters at baseline. Twelve months later, the BCVA was 80 letters and no obvious leakage of choroidal neovascularization could be observed (c). The retinal profile was normal (d).
